Literature DB >> 22318235

RB: mitotic implications of a tumour suppressor.

Amity L Manning1, Nicholas J Dyson.   

Abstract

RB, a well known tumour suppressor that functions in the control of cell cycle progression and proliferation, has recently been shown to have additional functions in the maintenance of genomic stability, such that inactivation of RB family proteins promotes chromosome instability (CIN) and aneuploidy. Several studies have provided potential explanations for these phenomena that occur following RB loss, and they suggest that this new function of RB may contribute to its role in tumour suppression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318235      PMCID: PMC3800194          DOI: 10.1038/nrc3216

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  70 in total

1.  Rb interacts with histone deacetylase to repress transcription.

Authors:  R X Luo; A A Postigo; D C Dean
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

2.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase.

Authors:  L Magnaghi-Jaulin; R Groisman; I Naguibneva; P Robin; S Lorain; J P Le Villain; F Troalen; D Trouche; A Harel-Bellan
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

3.  Retinoblastoma protein recruits histone deacetylase to repress transcription.

Authors:  A Brehm; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

4.  Retinoblastoma protein enhances the fidelity of chromosome segregation mediated by hsHec1p.

Authors:  L Zheng; Y Chen; D J Riley; P L Chen; W H Lee
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

5.  MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.

Authors:  L S Michel; V Liberal; A Chatterjee; R Kirchwegger; B Pasche; W Gerald; M Dobles; P K Sorger; V V Murty; R Benezra
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

6.  RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins.

Authors:  A Lai; J M Lee; W M Yang; J A DeCaprio; W G Kaelin; E Seto; P E Branton
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

7.  Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.

Authors:  A B Niculescu; X Chen; M Smeets; L Hengst; C Prives; S I Reed
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

8.  RB-dependent S-phase response to DNA damage.

Authors:  K E Knudsen; D Booth; S Naderi; Z Sever-Chroneos; A F Fribourg; I C Hunton; J R Feramisco; J Y Wang; E S Knudsen
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  pRB plays an essential role in cell cycle arrest induced by DNA damage.

Authors:  E A Harrington; J L Bruce; E Harlow; N Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

Review 10.  Aneuploidy and cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  74 in total

Review 1.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

2.  Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers?

Authors:  Tuba Sevimoglu; Kazim Yalcin Arga
Journal:  OMICS       Date:  2015-10-19

3.  Genetic landscape of esophageal squamous cell carcinoma.

Authors:  Yi-Bo Gao; Zhao-Li Chen; Jia-Gen Li; Xue-Da Hu; Xue-Jiao Shi; Zeng-Miao Sun; Fan Zhang; Zi-Ran Zhao; Zi-Tong Li; Zi-Yuan Liu; Yu-Da Zhao; Jian Sun; Cheng-Cheng Zhou; Ran Yao; Su-Ya Wang; Pan Wang; Nan Sun; Bai-Hua Zhang; Jing-Si Dong; Yue Yu; Mei Luo; Xiao-Li Feng; Su-Sheng Shi; Fang Zhou; Feng-Wei Tan; Bin Qiu; Ning Li; Kang Shao; Li-Jian Zhang; Lan-Jun Zhang; Qi Xue; Shu-Geng Gao; Jie He
Journal:  Nat Genet       Date:  2014-08-24       Impact factor: 38.330

4.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

5.  An RB insensitive to CDK regulation.

Authors:  Manel Joaquin; Eulàlia de Nadal; Francesc Posas
Journal:  Mol Cell Oncol       Date:  2016-12-14

6.  Disruption of CDK-resistant chromatin association by pRB causes DNA damage, mitotic errors, and reduces Condensin II recruitment.

Authors:  Charles A Ishak; Courtney H Coschi; Michael V Roes; Frederick A Dick
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

Review 7.  In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?

Authors:  Jonathan D Moore
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

8.  Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715.

Authors:  Roger B Slee; Brenda R Grimes; Ruchi Bansal; Jesse Gore; Corinne Blackburn; Lyndsey Brown; Rachel Gasaway; Jaesik Jeong; Jose Victorino; Keith L March; Riccardo Colombo; Brittney-Shea Herbert; Murray Korc
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

Review 9.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

10.  The retinoblastoma protein induces apoptosis directly at the mitochondria.

Authors:  Keren I Hilgendorf; Elizaveta S Leshchiner; Simona Nedelcu; Mindy A Maynard; Eliezer Calo; Alessandra Ianari; Loren D Walensky; Jacqueline A Lees
Journal:  Genes Dev       Date:  2013-04-25       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.